医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

NEWS > Home > > 疾病 > AIDS >

AHF Global World AIDS Day Events Focus On Testing and Treatment

2014年11月29日 AM10:10
このエントリーをはてなブックマークに追加


 

PHOTO: For World AIDS Day, AHF will host over 160 events around the world to promote testing, treatment for HIV/AIDS; international commemorations will launch global campaign to connect twenty million HIV-positive people to treatment by the end of 2020. For more information, visit www.aidshealth.org/wad (Click on the “Worldwide Events” tab for list of international events.)

For World AIDS Day, AHF will host over 160 events around the world to promote testing, treatment for ...

For World AIDS Day, AHF will host over 160 events around the world to promote testing, treatment for HIV/AIDS; international commemorations will launch global campaign to connect twenty million HIV-positive people to treatment by the end of 2020. For more information, visit www.aidshealth.org/wad (Click on the “Worldwide Events” tab for list of international events.) WHERE: An AHF healthcare worker administers an HIV test during the Cambodia Water Festival. WHEN: November 2014 (Photo: Business Wire)

WHERE: An AHF healthcare worker administers an HIV test during the Cambodia Water Festival
WHEN: November 2014

Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20141128005483/en/

CONTACT

AIDS Healthcare Foundation
Ged Kenslea, +1 323-308-1833 or
323-791-5526 (mobile)
ged.kenslea@aidshealth.org
or
Christopher
Johnson
, +1 323-960-4846 or 310-880-9913
(mobile)
christopher.johnson@aidshealth.org

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • Medidata宣布快速扩展其传感器云网络,再添10家卫生技术创新组织
  • ウォルグリーン・ブーツ・アライアンスが戦略的見直しを完了し、好業績のブーツ事業の所有権を保持することを決定
  • OliX Pharmaceuticals Announces IND Submission to U.S. FDA to Evaluate Safety and Tolerability of OLX10212 in Phase 1 Clinical Trial
  • DEXLEVO Strengthens Global Reputation of GOURI at IMCAS, the World’s Largest Beauty Anti-Aging Society
  • Sensorion Announces Approval in Australia to Initiate Proof of Concept Clinical Trial of SENS-401 for Residual Hearing Preservation During Cochlear Implantation